L
Lise Lotte Gluud
Researcher at University of Copenhagen
Publications - 241
Citations - 18781
Lise Lotte Gluud is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Cirrhosis & Medicine. The author has an hindex of 52, co-authored 201 publications receiving 16472 citations. Previous affiliations of Lise Lotte Gluud include Hvidovre Hospital & Cochrane Collaboration.
Papers
More filters
Journal ArticleDOI
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis
TL;DR: Treatment with beta carotene, vitamin A, vitamin E, and vitamin E may increase mortality and the potential roles of vitamin C and selenium on mortality need further study.
Journal ArticleDOI
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.
Lesley Wood,Matthias Egger,Lise Lotte Gluud,Kenneth F. Schulz,Peter Jüni,Douglas G. Altman,Christian Gluud,Richard M. Martin,Anthony J G Wood,Jonathan A C Sterne +9 more
TL;DR: The average bias associated with defects in the conduct of randomised trials varies with the type of outcome, andSystematic reviewers should routinely assess the risk of bias in the results of trials, and should report meta-analyses restricted to trials at low risk of biases.
Journal Article
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses (Annals of Internal Medicine (2008) 149, (219))
Lise Lotte Gluud,Kristian Thorlund,Christian Gluud,Lesley Woods,Ross J Harris,Jonathan A C Sterne +5 more
TL;DR: In this article, the authors studied the potential association between reported methodologic quality and intervention effects to assess whether discrepancies between the results of large and small randomized trials in meta-analyses.
Journal ArticleDOI
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.
Jelena Savović,Hayley E Jones,Douglas G. Altman,Ross J Harris,Peter Jüni,Julie Pildal,Bodil Als-Nielsen,Ethan M Balk,Christian Gluud,Lise Lotte Gluud,John P. A. Ioannidis,Kenneth F. Schulz,R Beynon,Nicky J Welton,Lesley Wood,David Moher,Jonathan J Deeks,Jonathan A C Sterne +17 more
TL;DR: For each characteristic, average bias and increases in between-trial heterogeneity were driven primarily by trials with subjective outcomes, with little evidence of bias in trials with objective and mortality outcomes.
Journal ArticleDOI
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
TL;DR: In this paper, the authors provide the best available information on the effect of anti-oxidants on mortality in patients with various diseases, including cancer, heart disease, and stroke.